logo
Plus   Neg
Share
Email

Vertex Pharmaceuticals Fires COO Ian Smith

Vertex Pharmaceuticals Inc. (VRTX) Wednesday said it has fired Chief Operating Officer and interim Chief Financial Officer Ian Smith due to personal behavior that violated the company's code.

Smith's termination is the result of personal behavior that violated Vertex's Code of Conduct and values and is unrelated to the Company's financial and business performance, the company said in a statement.

The company and the Board made this determination following a prompt and comprehensive investigation conducted with the assistance of independent external counsel, WilmerHale.

Paul Silva, Senior Vice President and the Company's Corporate Controller and Chief Accounting Officer since 2008, has been appointed interim CFO, effective immediately, while the Company conducts a formal search to identify a permanent CFO.

"At Vertex, we are deeply committed to our culture of diversity, inclusion and respect, and we insist that all of our employees, regardless of their seniority, live our values and adhere to our Code of Conduct," said Jeffrey Leiden, M.D., Ph.D., Chairman, President and Chief Executive Officer of Vertex. "This decision was not related to any conduct concerning the company's operations or finances."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Investment thesis - summary Strategy of getting multiple indication approvals for the same drug seems to be paying off for AstraZeneca PLC (AZN), in terms of higher likelihood of approval and improved sales. Besides, the company is realizing value from non-core, mature brands to invest in new drugs,... The Federal Trade Commission (FTC) and the New York State Office of the Attorney General jointly filed a complaint in federal court against Vyera Pharmaceuticals, LLC, and its CEO Martin Shkreli for allegedly engaging in anticompetitive schemes in order to maintain a monopoly over the life-saving drug Daraprim. While reporting financial results for the fourth quarter on Tuesday, Lockheed Martin Corp. (LMT) initiated earnings outlook for the full-year 2020, while boosting annual net sales outlook. For fiscal 2020, the company now expects earnings in a range of $23.65 to $23.95 per share. Net sales are now...
RELATED NEWS
Follow RTT
>